aspartic acid has been researched along with dipyridamole in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (40.00) | 18.7374 |
| 1990's | 8 (53.33) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Chan, TC; Kuczek, T | 1 |
| Hiddemann, W; Köhne-Wömpner, CH; Rustum, Y; Schmoll, HJ | 1 |
| Baselga, J; Casper, ES; Magill, GB; Markman, M; Ranhosky, A; Smart, TB | 1 |
| Chan, TC; Cleary, S; Howell, SB; Markman, M | 2 |
| Chan, TC; Howell, SB; King, ME; Taetle, R; Young, B | 1 |
| Chan, TC; Howell, SB | 1 |
| Brendel, BS | 1 |
| Nakane, M | 1 |
| Goz, B; Jeffs, L | 1 |
| Morán, J; Pasantes-Morales, H; Peña, C; Sánchez-Olea, R | 1 |
| Köhne, CH; Schmoll, HJ; Schöffski, P; Wilke, H | 1 |
| Capizzi, RL; Case, L; Fernandes, DJ; Fleming, RA; Homesley, H; Loggie, BW; Morris, R; Muss, HB; Richards, F; Russell, GB; Smith, S | 1 |
| Büchele, T; Dempke, W; Grothey, A; Schmoll, HJ | 1 |
2 review(s) available for aspartic acid and dipyridamole
| Article | Year |
|---|---|
The dead end of 5-fluorouracil double modulation and promise of continuous infusion schedules in the treatment of metastatic colorectal cancer.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Aspartate Carbamoyltransferase; Aspartic Acid; Clinical Trials, Phase II as Topic; Colorectal Neoplasms; Combined Modality Therapy; Dipyridamole; Drug Administration Schedule; Drug Synergism; Enzyme Inhibitors; Female; Fluorouracil; Humans; Immunologic Factors; Infusions, Intravenous; Injections, Intravenous; Interferons; Leucovorin; Liver Neoplasms; Male; Methotrexate; Middle Aged; Multicenter Studies as Topic; Neoplasm Proteins; Nucleotides; Palliative Care; Phosphonoacetic Acid; Randomized Controlled Trials as Topic; Thymidylate Synthase | 1996 |
Where do we stand with 5-fluorouracil?
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Chronotherapy; Colorectal Neoplasms; Dipyridamole; Drug Synergism; Fluorouracil; Humans; Interferons; Leucovorin; Levamisole; Methotrexate; Phosphonoacetic Acid; Radiation-Sensitizing Agents; Trimetrexate; Zidovudine | 1999 |
2 trial(s) available for aspartic acid and dipyridamole
| Article | Year |
|---|---|
A phase II trial of PALA + dipyridamole in patients with advanced soft-tissue sarcoma.
Topics: Adult; Aged; Antineoplastic Agents; Aspartic Acid; Dipyridamole; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Phosphonoacetic Acid; Sarcoma; Soft Tissue Neoplasms | 1991 |
Phase I study of N-(phosphonacetyl)-L-aspartate with fluorouracil and with or without dipyridamole in patients with advanced cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Aspartate Carbamoyltransferase; Aspartic Acid; Dipyridamole; Dose-Response Relationship, Drug; Female; Fluorouracil; Humans; Leukocytes; Male; Middle Aged; Neoplasms; Phosphonoacetic Acid; Uridine Triphosphate | 1996 |
11 other study(ies) available for aspartic acid and dipyridamole
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Mechanism-based model for tumor drug resistance.
Topics: Animals; Aspartic Acid; Cell Cycle; Cell Survival; Dipyridamole; Dose-Response Relationship, Drug; Drug Resistance; Models, Biological; Models, Statistical; Phosphonoacetic Acid; Pyrimidines; Tumor Cells, Cultured; Uridine | 1992 |
The emerging role for biomodulation of antineoplastic agents.
Topics: Antineoplastic Agents; Aspartic Acid; Dipyridamole; Fluorouracil; Humans; Immunologic Factors; Interferon-alpha; Phosphonoacetic Acid | 1992 |
Plasma uridine changes in cancer patients treated with the combination of dipyridamole and N-phosphonacetyl-L-aspartate.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Dipyridamole; Drug Evaluation; Female; Humans; Male; Middle Aged; Neoplasms; Organophosphorus Compounds; Phosphonoacetic Acid; Uridine | 1986 |
Phase I trial of combination therapy of cancer with N-phosphonacetyl-L-aspartic acid and dipyridamole.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Dipyridamole; Drug Evaluation; Drug Synergism; Female; Gastrointestinal Diseases; Headache; Humans; Male; Middle Aged; Neoplasms; Organophosphorus Compounds; Phosphonoacetic Acid; Uridine | 1987 |
Modulation of the activity of PALA by dipyridamole.
Topics: Animals; Aspartic Acid; Biological Transport; Cell Line; Colonic Neoplasms; Dipyridamole; Drug Interactions; Humans; In Vitro Techniques; Lethal Dose 50; Leukemia, Myeloid; Melanoma; Mice; Mice, Nude; Organophosphorus Compounds; Phosphonoacetic Acid; Pyrimidine Nucleosides; Tritium; Uridine | 1985 |
Mechanism of synergy between N-phosphonacetyl-L-aspartate and dipyridamole in a human ovarian carcinoma cell line.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Cell Line; Dipyridamole; Drug Synergism; Female; Humans; Nucleotides; Organophosphorus Compounds; Ovarian Neoplasms; Phosphonoacetic Acid; Uridine | 1985 |
[Cardiovascular complications in operated patients more than 70 years old suffering from cardiovascular insufficiency].
Topics: Age Factors; Aged; Aminophylline; Anesthesia, General; Aspartic Acid; Cardiac Surgical Procedures; Dipyridamole; Female; Glucose; Heart Failure; Humans; Lanatosides; Magnesium; Male; Postoperative Care; Postoperative Complications; Potassium; Premedication; Preoperative Care; Vascular Diseases | 1972 |
[Experimental study on the selective intracoronary infusion, with special reference to its effect on acute coronary stenosis].
Topics: Acute Disease; Animals; Aspartic Acid; Cardiac Catheterization; Cardiac Output; Coronary Disease; Coronary Vessels; Cytochromes; Dextrans; Dipyridamole; Dogs; Electrocardiography; Heparin; Infusions, Parenteral; Methods; Myocardium; Nucleosides; Oxidation-Reduction; Oxygen Consumption; Regional Blood Flow; Thiamine | 1968 |
The enhancement of the frequency of resistance to N-phosphonoacetyl-L-aspartate and methotrexate by 1-beta-D-arabinofuranosylcytosine: the effect of dipyridamole.
Topics: Animals; Aspartic Acid; Cell Line, Transformed; Cricetinae; Cytarabine; Dipyridamole; Drug Resistance; Drug Synergism; Humans; Methotrexate; Nucleosides; Phosphonoacetic Acid; Thioinosine | 1994 |
Inhibition of volume regulation and efflux of osmoregulatory amino acids by blockers of Cl- transport in cultured astrocytes.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Animals; Aspartic Acid; Astrocytes; Cells, Cultured; Chloride Channels; Chlorides; Dipyridamole; Dose-Response Relationship, Drug; Kinetics; Niflumic Acid; Rats; Taurine; Tritium; Water-Electrolyte Balance | 1993 |